Arama Sonuçları - Роберто Пили
- Gösterilen 1 - 20 sonuçlar arası kayıtlar. 79
- Sonraki Sayfaya Git
-
1
Class I histone deacetylase inhibition is a novel mechanism to target regulatory T cells in immunotherapy Yazar: Li Shen, Роберто Пили
Baskı/Yayın Bilgisi 2012Artigo -
2
Histone Deacetylase Inhibitors: Advancing Therapeutic Strategies in Hematological and Solid Malignancies Yazar: Leigh Ellis, Роберто Пили
Baskı/Yayın Bilgisi 2010Artigo -
3
Targeting tumor angiogenesis with histone deacetylase inhibitors Yazar: Leigh Ellis, Hans J. Hammers, Роберто Пили
Baskı/Yayın Bilgisi 2008Revisão -
4
Mechanisms of action of tasquinimod on the tumour microenvironment Yazar: Éric Raymond, Angus Dalgleish, J.‐E. Damber, Matthew R. Smith, Роберто Пили
Baskı/Yayın Bilgisi 2013Revisão -
5
Combinatorial antitumor effect of HDACs and the PI3K-Akt-mTOR pathway inhibition in a Pten deficient model of prostate cancer Yazar: Leigh Ellis, Sheng‐Yu Ku, Swathi Ramakrishnan, Elena Lasorsa, Gizzou Azabdaftari, Alejandro Godoy, Роберто Пили
Baskı/Yayın Bilgisi 2013Artigo -
6
Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor... Yazar: Sreenivasulu Chintala, Tanbir Najrana, Károly Tóth, Shousong Cao, Farukh A. Durrani, Роберто Пили, Youcef M. Rustum
Baskı/Yayın Bilgisi 2012Artigo -
7
Telemedicine, e-Health, and Digital Health Equity: A Scoping Review Yazar: Донателла Рита Петретто, Gian Pietro Carrogu, Luca Gaviano, Roberta Berti, Martina Pinna, A Petretto, Роберто Пили
Baskı/Yayın Bilgisi 2024Revisão -
8
Definitions of Ageing According to the Perspective of the Psychology of Ageing: A Scoping Review Yazar: Luca Gaviano, Роберто Пили, A Petretto, Roberta Berti, Gian Pietro Carrogu, Martina Pinna, Донателла Рита Петретто
Baskı/Yayın Bilgisi 2024Revisão -
9
The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic... Yazar: Daniel Keizman, Maya Ish‐Shalom, Peng Huang, Mario A. Eisenberger, Роберто Пили, Hans J. Hammers, Michael A. Carducci
Baskı/Yayın Bilgisi 2011Artigo -
10
Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours Yazar: Роберто Пили, Brenda Salumbides, Ming Zhao, Soner Altiok, David Z. Qian, James A. Zwiebel, Michael A. Carducci, Michelle A. Rudek
Baskı/Yayın Bilgisi 2011Artigo -
11
Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examination Yazar: Daniel Keizman, Peng Huang, Mario A. Eisenberger, Роберто Пили, Jenny J. Kim, Emmanuel S. Antonarakis, Hans J. Hammers, Michael A. Carducci
Baskı/Yayın Bilgisi 2011Artigo -
12
Class II Histone Deacetylases Are Associated with VHL-Independent Regulation of Hypoxia-Inducible Factor 1α Yazar: David Z. Qian, Sushant K. Kachhap, Spencer J. Collis, Henk M.W. Verheul, Michael A. Carducci, Peter Atadja, Роберто Пили
Baskı/Yayın Bilgisi 2006Artigo -
13
Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cells Yazar: Rosalba Minelli, Roberta Cavalli, Leigh Ellis, Piergiorgio Pettazzoni, Francesco Trotta, Eric Ciamporcero, Giuseppina Barrera, Roberto Fantozzi, Chiara Dianzani, Роберто Пили
Baskı/Yayın Bilgisi 2012Artigo -
14
Restriction of dietary protein decreases mTORC1 in tumors and somatic tissues of a tumor-bearing mouse xenograft model Yazar: Dudley W. Lamming, Nicole E. Cummings, Antonella Rastelli, Feng Gao, Edda Cava, Beatrice Bertozzi, Francesco Spelta, Роберто Пили, Luigi Fontana
Baskı/Yayın Bilgisi 2015Artigo -
15
Class I Histone Deacetylase Inhibitor Entinostat Suppresses Regulatory T Cells and Enhances Immunotherapies in Renal and Prostate Cancer Models Yazar: Li Shen, Michael J. Ciesielski, Swathi Ramakrishnan, Kiersten Marie Miles, Leigh Ellis, Paula Sotomayor, Protul Shrikant, Robert A. Fenstermaker, Роберто Пили
Baskı/Yayın Bilgisi 2012Artigo -
16
Combination Strategy Targeting the Hypoxia Inducible Factor-1α with Mammalian Target of Rapamycin and Histone Deacetylase Inhibitors Yazar: Henk M.W. Verheul, Brenda Salumbides, Karen van Erp, Hans J. Hammers, David Z. Qian, Tolib B. Sanni, Peter Atadja, Роберто Пили
Baskı/Yayın Bilgisi 2008Artigo -
17
Antitumor effect of the histone deacetylase inhibitor LAQ824 in combination with 13-<i>cis</i>-retinoic acid in human malignant melanoma Yazar: Yukihiko Kato, Brenda Salumbides, Xiao-Fei Wang, David Z. Qian, Simon A. Williams, Yongfeng Wei, Tolib B. Sanni, Peter Atadja, Роберто Пили
Baskı/Yayın Bilgisi 2007Artigo -
18
Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer Yazar: Eric Ciamporcero, Martina Daga, Stefania Pizzimenti, Antonella Roetto, Chiara Dianzani, Alessandra Compagnone, A Palmieri, Chiara Ullio, Luigi Cangemi, Роберто Пили, Giuseppina Barrera
Baskı/Yayın Bilgisi 2017Artigo -
19
Data-Independent Acquisition Phosphoproteomics of Urinary Extracellular Vesicles Enables Renal Cell Carcinoma Grade Differentiation Yazar: Marco Hadisurya, Zheng-Chi Lee, Zhuojun Luo, Guiyuan Zhang, Yajie Ding, Hao Zhang, Anton Iliuk, Роберто Пили, Ronald S. Boris, W. Andy Tao
Baskı/Yayın Bilgisi 2023Artigo -
20
Dietary protein restriction inhibits tumor growth in human xenograft models of prostate and breast cancer Yazar: Luigi Fontana, Remi Adelaiye‐Ogala, Antonella Rastelli, Kiersten Marie Miles, Eric Ciamporcero, Valter D. Longo, Holly M. Nguyen, Robert L. Vessella, Роберто Пили
Baskı/Yayın Bilgisi 2013Artigo
Arama Araçları:
İlgili Konular
Medicine
Internal medicine
Cancer
Oncology
Cancer research
Biology
Biochemistry
Gene
Renal cell carcinoma
Prostate cancer
Sunitinib
Chemistry
Genetics
Pharmacology
Pathology
Histone
Histone deacetylase
Angiogenesis
Cell biology
Gastroenterology
Adverse effect
Chemotherapy
Urology
Apoptosis
Progression-free survival
Clinical endpoint
Clinical trial
Immunology
Immune system
In vitro